inflammatory bowel disease
COVID-19 Vaccination for Patients With IBD: Don’t Hold Meds
Patients with IBD can safely continue biologic drugs around the time they receive mRNA COVID-19 vaccination, ...
FEBRUARY 21, 2023
Leveraging the EHR Among Tools for Boosting Biosimilars
Despite the promise of huge savings with biosimilars—an estimated $140 billion in discounted spending over ...
OCTOBER 28, 2021
Nearly 1 in 3 IBD Patients Stops Biologic Therapy Within 18 Months
Almost one-third of people followed in an inflammatory bowel disease registry stopped biologic therapy within 1.5 ...
OCTOBER 26, 2021
Can Sunflower Seeds Relieve Abdominal Pain?
A synthetically optimized peptide naturally found in sunflower seeds may be a promising drug for treating pain ...
OCTOBER 8, 2021
Pharmacists Show Their Skill In Easing Biosimilar Switches
Managing biosimilar adoption and utilization has become almost a specialty in itself for many health-system ...
JULY 29, 2021
Novel Opioid Targets Bowel Without Respiratory Depression in Preclinical Study
Researchers have found that a novel opioid reduced inflammatory bowel pain just as well as conventional opioids ...
JULY 7, 2021
Come Together to Increase Biosimilar Uptake
The use of biosimilars could be higher if stakeholders, from manufacturers to payors and pharmacists, united to ...
MAY 27, 2021
IBD Patients Report Their Reactions To Biological Therapies
When IBD patients self-report their adverse reactions to biological therapies, they could provide insights that ...
APRIL 26, 2021
Virtual Reality Treatment Shows Promise For IBD, Abdominal Pain
Virtual reality aimed at easing stress may be an adjunctive therapy for children and adults with inflammatory bowel ...
APRIL 15, 2021
Hypnosis Found to Aid IBD Outcomes in Peds
Clinical hypnosis can be an effective therapy for treating inflammatory bowel disease in children, promoting ...
MARCH 26, 2021
ON PAIN: SCS Trial Shows Benefit for Chronic Pelvic Pain Patients
Causes of chronic pelvic pain can span different organ systems—genital, urinary or intestinal, for ...
MARCH 24, 2021
Early Safety Results Show Increased Risk for Serious Heart Issues, Cancer From Arthritis Drug
The FDA reported preliminary results from a safety trial of the arthritis drug tofacitinib, showing increased risk ...
FEBRUARY 8, 2021
